PFAS Settlement Calculator 2026: Estimate Your Claim Value
Use the PFAS settlement calculator to organize potential personal-injury claim factors involving AFFF firefighting foam or PFAS-contaminated water, including exposure source, diagnosis, treatment, economic losses, evidence strength, defendants and filing considerations.
- Separates personal-injury claims from public-water-system settlements.
- Uses the latest August JPML count and July 30 court orders.
- Distinguishes conditions discussed in health research from conditions being litigated.
- Links into the current PFAS lawsuit, AFFF, settlement-amount and update hierarchy.
- Explains why a PFAS blood test can document body burden but cannot identify exposure source or prove causation by itself.
Get Your Free PFAS Claim Estimate
Answer questions about AFFF or contaminated-water exposure, diagnosis, treatment, financial losses and supporting evidence.
PFAS / AFFF MDL 2873 Status in August 2026
In re: Aqueous Film-Forming Foams Products Liability Litigation, MDL No. 2873, is centralized in the U.S. District Court for the District of South Carolina before Judge Richard M. Gergel. The MDL includes personal-injury, medical-monitoring, property, public-water-system and other PFAS-related claims.
15,246 Pending Actions
The August 3, 2026 JPML report lists 15,246 actions pending and 19,822 historical actions associated with MDL 2873.
Group B Deadline Moved
CMO 26O, entered July 30, moved the Group B selection and expert-discovery proposal deadline from July 20 to November 20, 2026. The order addresses thyroid-disease and ulcerative-colitis bellwether plaintiffs.
Rule 702 Briefing
CMO 33E sets August 24, 2026 for Rule 702 motions concerning general-causation experts related to thyroid cancer and/or liver cancer, followed by October 8 responses and November 2 replies.
Who May Need a PFAS or AFFF Lawsuit Review?
Potential personal-injury claims are fact-specific. A useful review generally looks at how exposure occurred, which PFAS or products may be involved, the diagnosis, latency, medical evidence, defendant identification, damages and governing law.
Facts That May Support Closer Review
- Documented occupational, military, airport, firefighting, industrial or contaminated-water exposure
- Kidney or testicular cancer with a plausible PFOA/PFAS exposure history
- Another serious diagnosis currently being evaluated in the litigation or supported by relevant scientific evidence
- Medical records showing diagnosis, treatment, prognosis and a consistent timeline
- AFFF, employer, military-base, water-system, location or contamination records supporting exposure
- Medical bills, lost earnings, disability or other documented damages
Claims Requiring More Individual Review
- Exposure is suspected but source, product, location or dates are uncertain
- A PFAS blood test exists without evidence identifying the source or timing of exposure
- The diagnosis has limited or disputed evidence for the particular PFAS and exposure level
- There is exposure but no diagnosed injury or legally recognized damages
- The potential statute of limitation, statute of repose or notice deadline is uncertain
- Multiple environmental or occupational exposures complicate causation
Illustrative PFAS Settlement Ranges
These ranges are educational planning bands—not reported personal-injury averages, court-approved tiers or guaranteed settlements. They are aligned with TortAdvisor’s current PFAS Settlement Amounts research page.
No Diagnosed Compensable Injury
Not Reliably EstimablePotential monitoring, property or other claims require separate legal analysis. Exposure alone does not create a dependable personal-injury value.
No universal personal-injury value.Lower-Impact Documented Claim
$75K–$150KDocumented exposure plus a supported condition, treatment and measurable damages, but less severe impairment or weaker economic loss.
TortAdvisor editorial estimate only.Serious Disease Claim
$150K–$300KSerious diagnosis, stronger exposure evidence, substantial treatment and meaningful economic or quality-of-life impact.
TortAdvisor editorial estimate only.Severe Cancer / Permanent Harm
$300K–$500K+Severe or advanced disease, permanent impairment, strong exposure proof, substantial treatment or unusually high economic loss.
Catastrophic or wrongful-death claims can require separate review and may fall outside this range.3M and DuPont-Family Water Settlements Are Not Individual Cancer Payouts
Large public-water-system settlements are important PFAS litigation milestones, but they resolve defined drinking-water-provider claims rather than creating automatic compensation for individual personal-injury claimants.
3M Public Water Systems
3M’s 2025 Form 10-K states that its public-water-system settlement, approved in 2024, calls for total payments of approximately $10.5 billion to $12.5 billion, with payments extending through 2036.
Chemours / DuPont / Corteva
The companies announced a $1.185 billion fund to resolve defined PFAS-related drinking-water claims of a class of U.S. public water systems.
PFAS Health Associations: What Federal Health Agencies Actually Say
ATSDR states that epidemiological evidence suggests associations between increases in exposure to specific PFAS and several health effects. For PFOA, ATSDR identifies evidence of an association with kidney and testicular cancer. Its clinician guidance also notes sufficient evidence of an association for kidney cancer and limited or suggestive evidence for testicular cancer under the National Academies framework.
EPA’s current PFAS health-risk page lists an increased risk of some cancers—including prostate, kidney and testicular cancers—among health effects that may occur with exposure to certain levels of PFAS. Research remains ongoing, and the strength of evidence differs by compound, disease and exposure history.
Evidence Attorneys May Review in a PFAS Claim
- Military, airport, firefighting or industrial work history
- AFFF use, training, purchasing or incident records
- Water-system test results and contamination notices
- Addresses and dates near potential PFAS sources
- PFAS blood-test results, when available
- Pathology, imaging and specialist records
- Diagnosis and treatment dates
- Surgery, chemotherapy or other treatment records
- Medical bills and out-of-pocket expenses
- Lost wages and reduced earning capacity
- Disability and caregiving documentation
- Product, manufacturer or location evidence
6 Factors That Can Affect PFAS Claim Value
1. Exposure Pathway
Direct AFFF use, occupational contact, contaminated drinking water, location evidence and duration can affect proof.
2. Diagnosis
Cancer type or other disease, stage, severity and competing risk factors can affect both causation and damages.
3. Treatment & Prognosis
Surgery, chemotherapy, hospitalization, recurrence, permanent impairment and future care can affect damages.
4. Economic Loss
Medical costs, lost earnings, reduced earning capacity, travel, caregiving and household-service loss may be relevant.
5. Product & Location Proof
Records identifying AFFF products, manufacturers, worksites, water systems and contamination sources can be critical.
6. Law & Defenses
Jurisdiction, limitations, repose, defendant-specific defenses and federal MDL orders can materially affect viability and value.
PFAS Lawsuit Filing Deadlines Vary by Claim and State
There is no single nationwide deadline for every PFAS or AFFF personal-injury claim. Time limits can depend on state law, diagnosis, discovery, exposure, defendant, claim type, statutes of repose, government-notice rules and MDL orders.
PFAS, AFFF, Settlement & Litigation Resources
This page now links to the current PFAS lawsuit and settlement destinations instead of the older slugs in the uploaded version.
PFAS Settlement Calculator FAQ
Is the PFAS settlement calculator an exact prediction?
No. It is an educational estimate based on limited inputs and cannot account for every medical record, expert opinion, defense, jurisdictional rule, filing deadline or future court development.
What is the average PFAS personal-injury settlement in 2026?
No official court-approved average or nationwide personal-injury payout matrix has been announced. Public-water-system settlements should not be treated as individual cancer payouts.
How many AFFF MDL cases are pending?
The August 3, 2026 JPML report lists 15,246 pending actions and 19,822 historical actions for MDL 2873.
What happened to the July 20 Group B deadline?
CMO 26O moved the selection and expert-discovery proposal deadline to November 20, 2026.
Is a PFAS blood test required?
Requirements depend on the claim and legal strategy. ATSDR explains that blood testing has significant limits and does not identify a disease, exposure source or exposure date by itself.
Do I have to request attorney contact to use the calculator?
No. The educational estimate and any request for attorney or expert contact should remain separate. Optional contact consent should remain unchecked by default.
Request a Confidential PFAS / AFFF Claim Review
If you have documented AFFF or PFAS-contaminated-water exposure and a serious diagnosis, use the calculator to organize the facts or request a confidential screening.
PFAS Litigation, Health & Settlement Sources
JPML — August 3, 2026 Pending MDL Report
Official source for the 15,246 pending / 19,822 historical MDL 2873 action count.
Open JPML report →U.S. District Court — MDL 2873
Official District of South Carolina AFFF multidistrict-litigation page before Judge Richard M. Gergel.
Open MDL 2873 page →CMO 26O — Group B Schedule
July 30, 2026 order moving Group B selection and expert-discovery proposals to November 20, 2026.
Open CMO 26O →CMO 33E — Rule 702 Schedule
July 30, 2026 order setting the thyroid/liver-cancer expert-motion schedule beginning August 24, 2026.
Open CMO 33E →ATSDR — PFAS Health Effects
Federal health-agency summary of epidemiological associations involving specific PFAS and health outcomes.
Open ATSDR health source →ATSDR — PFAS Blood Testing
Federal guidance explaining what PFAS blood tests can and cannot establish.
Open ATSDR testing source →EPA — Current PFAS Health-Risk Understanding
Current EPA summary of health effects associated with exposure to certain levels of PFAS.
Open EPA PFAS source →3M SEC Filing — Public-Water Settlement
3M’s 2025 Form 10-K describes the approved public-water-system settlement and expected total payments.
Open 3M SEC filing →DuPont / Chemours / Corteva Water Settlement
Company announcement describing the $1.185 billion defined public-water-system settlement fund.
Open settlement announcement →
